BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34074330)

  • 1. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.
    Rizzo G; Bertotti A; Leto SM; Vetrano S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):178. PubMed ID: 34074330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.
    Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA
    Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the development of transplanted colorectal cancer mouse models.
    Yang YS; Liu CY; Wen D; Gao DZ; Lin S; He HF; Zhao XF
    Transl Res; 2022 Nov; 249():128-143. PubMed ID: 35850446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
    Ding L; Yang Y; Lu Q; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening.
    Castro F; Leite Pereira C; Helena Macedo M; Almeida A; José Silveira M; Dias S; Patrícia Cardoso A; José Oliveira M; Sarmento B
    Adv Drug Deliv Rev; 2021 Aug; 175():113824. PubMed ID: 34090966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
    Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
    J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
    Vlachogiannis G; Hedayat S; Vatsiou A; Jamin Y; Fernández-Mateos J; Khan K; Lampis A; Eason K; Huntingford I; Burke R; Rata M; Koh DM; Tunariu N; Collins D; Hulkki-Wilson S; Ragulan C; Spiteri I; Moorcraft SY; Chau I; Rao S; Watkins D; Fotiadis N; Bali M; Darvish-Damavandi M; Lote H; Eltahir Z; Smyth EC; Begum R; Clarke PA; Hahne JC; Dowsett M; de Bono J; Workman P; Sadanandam A; Fassan M; Sansom OJ; Eccles S; Starling N; Braconi C; Sottoriva A; Robinson SP; Cunningham D; Valeri N
    Science; 2018 Feb; 359(6378):920-926. PubMed ID: 29472484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in three-dimensional tumor models for colorectal cancer].
    Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
    Pyo DH; Hong HK; Lee WY; Cho YB
    Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases.
    Ceelen W; Ramsay RG; Narasimhan V; Heriot AG; De Wever O
    Trends Cancer; 2020 Mar; 6(3):236-246. PubMed ID: 32101726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions.
    He R; Huang S; Lu J; Su L; Gao X; Chi H
    Front Immunol; 2024; 15():1362709. PubMed ID: 38415252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer murine models: Initiation to metastasis.
    Pothuraju R; Khan I; Jain M; Bouvet M; Malafa M; Roy HK; Kumar S; Batra SK
    Cancer Lett; 2024 Apr; 587():216704. PubMed ID: 38360138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy.
    Mo S; Tang P; Luo W; Zhang L; Li Y; Hu X; Ma X; Chen Y; Bao Y; He X; Fu G; Xu X; Rao X; Li X; Guan R; Chen S; Deng Y; Lv T; Mu P; Zheng Q; Wang S; Liu F; Li Y; Sheng W; Huang D; Hu C; Gao J; Zhang Z; Cai S; Clevers H; Peng J; Hua G
    Adv Sci (Weinh); 2022 Nov; 9(31):e2204097. PubMed ID: 36058001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
    Subtil B; Iyer KK; Poel D; Bakkerus L; Gorris MAJ; Escalona JC; van den Dries K; Cambi A; Verheul HMW; de Vries IJM; Tauriello DVF
    Front Immunol; 2023; 14():1105244. PubMed ID: 36761758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
    Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
    Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.